title: Management of side effects of novel therapies for multiple myeloma: consensus statements developed by the International Myeloma Foundation's Nurse Leadership Board.
abstract: Nurses play an essential role in managing the care of patients with multiple myeloma, who require education and support to receive and adhere to optimal therapy. The International Myeloma Foundation created a Nurse Leadership Board comprised of oncology nurses from leading cancer centers and community practices. An assessment survey identified the need for specific recommendations for managing key side effects of novel antimyeloma agents. Myelosuppression, thromboembolic events, peripheral neuropathy, steroid toxicities, and gastrointestinal side effects were selected for the first consensus statements. The board developed recommendations for healthcare providers in any medical setting, including grading of side-effect toxicity and strategies for managing the side effects in general, with specific recommendations pertaining to the novel agents.
authors.affiliation: Cedars-Sinai Outpatient Cancer Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA. page.bertolotti@cshs.org
authors.forename: Page
authors.initials: P
authors.lastname: Bertolotti
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Bilotti
authors.forename: Kathleen
authors.initials: K
authors.lastname: Colson
authors.forename: Kathleen
authors.initials: K
authors.lastname: Curran
authors.forename: Deborah
authors.initials: D
authors.lastname: Doss
authors.forename: Beth
authors.initials: B
authors.lastname: Faiman
authors.forename: Maria
authors.initials: M
authors.lastname: Gavino
authors.forename: Bonnie
authors.initials: B
authors.lastname: Jenkins
authors.forename: Kathy
authors.initials: K
authors.lastname: Lilleby
authors.forename: Ginger
authors.initials: G
authors.lastname: Love
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Mangan
authors.forename: Emily
authors.initials: E
authors.lastname: McCullagh
authors.forename: Teresa
authors.initials: T
authors.lastname: Miceli
authors.forename: Kena
authors.initials: K
authors.lastname: Miller
authors.forename: Kathryn
authors.initials: K
authors.lastname: Rogers
authors.forename: Sandra
authors.initials: S
authors.lastname: Rome
authors.forename: Stacey
authors.initials: S
authors.lastname: Sandifer
authors.forename: Lisa C
authors.initials: LC
authors.lastname: Smith
authors.forename: Joseph D
authors.initials: JD
authors.lastname: Tariman
authors.forename: Jeanne
authors.initials: J
authors.lastname: Westphal
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007857:Leadership; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000451:nursing; D012956:Societies, Nursing
chemical_list: D000970:Antineoplastic Agents